Literature DB >> 14671487

Inflammatory bowel disease in African Americans.

Sarathchandra I Reddy1, Robert Burakoff.   

Abstract

Ulcerative colitis (UC) and Crohn's disease (CD) are idiopathic inflammatory disorders of the gastrointestinal tract. The two disorders encompass a wide spectrum of clinical presentations and are diagnosed on the basis of their clinical, endoscopic, radiologic, and histologic features. Combined, the two disorders affect approximately 800,000 patients in the United States. An assessment of the epidemiology of these disorders is complicated by a wide range of factors including the absence of population based registries in ethnically diverse regions, the use of retrospective data, and highly variable clinical presentations which may delay or obscure the diagnosis. In this paper we review the available data regarding the epidemiology, clinical presentation, and clinical course of inflammatory bowel disease in African Americans.

Entities:  

Mesh:

Year:  2003        PMID: 14671487     DOI: 10.1097/00054725-200311000-00006

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  8 in total

Review 1.  Epidemiology and risk factors for IBD.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-03       Impact factor: 46.802

Review 2.  Ulcerative colitis in smokers, non-smokers and ex-smokers.

Authors:  Guillermo Bastida; Belén Beltrán
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

3.  A comparison of abdominal surgical outcomes between African-American and Caucasian Crohn's patients.

Authors:  Nicole Griglione; Shadi Yarandi; Jahnavi Srinivasan; Thomas Ahearn; Tanvi Dhere
Journal:  Int J Colorectal Dis       Date:  2014-05-15       Impact factor: 2.571

4.  African-American inflammatory bowel disease in a Southern U.S. health center.

Authors:  Hemanth Veluswamy; Kunal Suryawala; Ankur Sheth; Shannon Wells; Erik Salvatierra; Walter Cromer; Ganta V Chaitanya; Annette Painter; Mihir Patel; Kenneth Manas; Ellenmarie Zwank; Moheb Boktor; Kondal Baig; Balaji Datti; Michael J Mathis; Alireza Minagar; Paul A Jordan; Jonathan S Alexander
Journal:  BMC Gastroenterol       Date:  2010-09-09       Impact factor: 3.067

5.  Demographic characteristics of hospitalized IBD patients.

Authors:  Amnon Sonnenberg
Journal:  Dig Dis Sci       Date:  2009-11       Impact factor: 3.199

6.  Bacterial superantigens and T cell receptor beta-chain-bearing T cells in the immunopathogenesis of ulcerative colitis.

Authors:  N Shiobara; Y Suzuki; H Aoki; A Gotoh; Y Fujii; Y Hamada; S Suzuki; N Fukui; I Kurane; T Itoh; R Suzuki
Journal:  Clin Exp Immunol       Date:  2007-07-05       Impact factor: 4.330

7.  Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs.

Authors:  Sarah Alrubia; Jialin Mao; Yuan Chen; Jill Barber; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2022-09-03       Impact factor: 5.577

8.  Inflammatory bowel disease in African American children compared with other racial/ethnic groups in a multicenter registry.

Authors:  Jolanda M White; Siobhán O'Connor; Harland S Winter; Melvin B Heyman; Barbara S Kirschner; George D Ferry; Stanley A Cohen; Robert N Baldassano; Terry Smith; Traci Clemons; Benjamin D Gold
Journal:  Clin Gastroenterol Hepatol       Date:  2008-10-09       Impact factor: 11.382

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.